// App-Quantinova.ai

7080 : Circulating tumor cell (CTC) as a significant clinical marker in epithelioid-type malignant pleural mesothelioma (MPM).

Researchers

Presenter

  • Kazue Yoneda

Principal Investigators

  • Fumihiro Tanaka

  • Shunichi Fukuda

  • Noriaki Tsubota

  • Kazuya Fukuoka

  • Takashi Nakano

  • Seiki Hasegawa

  • Hayato Orui

  • Masaki Hashimoto

  • Teruhisa Takuwa

  • Yoshitomo Okumura

  • Seiji Matsumoto

  • Nobuyuki Kondo

  • Ayuko Sato

  • Tohru Tsujimura

Medical Centers

  • University of Occupational and Environmental Health, Kitakyushu, Japan

  • Inagi Municipal Hospital, Inagi, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Malignant pleural mesothelioma

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A